These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30188751)

  • 41. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
    Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
    PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ileal smooth muscle dysfunction and remodeling in cystic fibrosis.
    Risse PA; Kachmar L; Matusovsky OS; Novali M; Gil FR; Javeshghani S; Keary R; Haston CK; Michoud MC; Martin JG; Lauzon AM
    Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G1-8. PubMed ID: 22538405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function.
    Arora K; Naren AP
    Curr Drug Targets; 2016; 17(11):1275-81. PubMed ID: 26648081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation of a conditional null allele for Cftr in mice.
    Hodges CA; Cotton CU; Palmert MR; Drumm ML
    Genesis; 2008 Oct; 46(10):546-52. PubMed ID: 18802965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.
    Ramalho AS; Beck S; Meyer M; Penque D; Cutting GR; Amaral MD
    Am J Respir Cell Mol Biol; 2002 Nov; 27(5):619-27. PubMed ID: 12397022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cystic fibrosis: relationship between genotype and phenotype].
    Bienvenu T
    Arch Pediatr; 2003 Sep; 10 Suppl 2():318s-324s. PubMed ID: 14671928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The HDAC inhibitor SAHA does not rescue CFTR membrane expression in Cystic Fibrosis.
    Bergougnoux A; Petit A; Knabe L; Bribes E; Chiron R; De Sario A; Claustres M; Molinari N; Vachier I; Taulan-Cadars M; Bourdin A
    Int J Biochem Cell Biol; 2017 Jul; 88():124-132. PubMed ID: 28478266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis.
    Magalhães M; Rivals I; Claustres M; Varilh J; Thomasset M; Bergougnoux A; Mely L; Leroy S; Corvol H; Guillot L; Murris M; Beyne E; Caimmi D; Vachier I; Chiron R; De Sario A
    Clin Epigenetics; 2017; 9():19. PubMed ID: 28289476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevation of hepatic sulphotransferase activities in mice with resistance to cystic fibrosis.
    Falany JL; Greer H; Kovacs T; Sorscher EJ; Falany CN
    Biochem J; 2002 May; 364(Pt 1):115-20. PubMed ID: 11988083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium.
    Hodges CA; Grady BR; Mishra K; Cotton CU; Drumm ML
    Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G528-36. PubMed ID: 21659619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel Approaches for Potential Therapy of Cystic Fibrosis.
    Sawczak V; Getsy P; Zaidi A; Sun F; Zaman K; Gaston B
    Curr Drug Targets; 2015; 16(9):923-36. PubMed ID: 25557257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine.
    Norkina O; Burnett TG; De Lisle RC
    Infect Immun; 2004 Oct; 72(10):6040-9. PubMed ID: 15385508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abnormal enamel development in a cystic fibrosis transgenic mouse model.
    Wright JT; Kiefer CL; Hall KI; Grubb BR
    J Dent Res; 1996 Apr; 75(4):966-73. PubMed ID: 8708137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CFTR Influences Beta Cell Function and Insulin Secretion Through Non-Cell Autonomous Exocrine-Derived Factors.
    Sun X; Yi Y; Xie W; Liang B; Winter MC; He N; Liu X; Luo M; Yang Y; Ode KL; Uc A; Norris AW; Engelhardt JF
    Endocrinology; 2017 Oct; 158(10):3325-3338. PubMed ID: 28977592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. mRNA-based detection of rare CFTR mutations improves genetic diagnosis of cystic fibrosis in populations with high genetic heterogeneity.
    Felício V; Ramalho AS; Igreja S; Amaral MD
    Clin Genet; 2017 Mar; 91(3):476-481. PubMed ID: 27174726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vardenafil reduces macrophage pro-inflammatory overresponses in cystic fibrosis through PDE5- and CFTR-dependent mechanisms.
    Noel S; Panin N; Beka M; Dhooghe B; Huaux F; Leal T
    Clin Sci (Lond); 2017 Jun; 131(11):1107-1121. PubMed ID: 28196856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mineral content of calcified tissues in cystic fibrosis mice.
    Gawenis LR; Spencer P; Hillman LS; Harline MC; Morris JS; Clarke LL
    Biol Trace Elem Res; 2001 Oct; 83(1):69-81. PubMed ID: 11694004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Severe osteopenia in CFTR-null mice.
    Dif F; Marty C; Baudoin C; de Vernejoul MC; Levi G
    Bone; 2004 Sep; 35(3):595-603. PubMed ID: 15336594
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential genetic modifiers of the cystic fibrosis intestinal inflammatory phenotype on mouse chromosomes 1, 9, and 10.
    Norkina O; De Lisle RC
    BMC Genet; 2005 May; 6():29. PubMed ID: 15921521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.